HCW Biologics (HCWB) Change in Acquisitions & Divestments (2022 - 2023)
HCW Biologics' (HCWB) quarterly Change in Acquisitions & Divestments came in at $10.0 million in Q3 2023, down 41.12% YoY from $17.0 million in Q3 2022, and down 41.12% on a QoQ basis from $17.0 million in Q3 2022.
HCW Biologics (HCWB) Change in Acquisitions & Divestments (2022 - 2023) Analysis & Trends
HCW Biologics (HCWB) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $10.0 million in Q3 2023.
- Quarterly Change in Acquisitions & Divestments fell 41.12% year-over-year to $10.0 million in Q3 2023, while the trailing twelve-month figure through Dec 2024 was $10.0 million (changed 0.0% YoY) and the FY2023 annual result came in at $10.0 million, down 59.97% from the prior year.
- Change in Acquisitions & Divestments declined to $10.0 million in Q3 2023, from $17.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $17.0 million in Q3 2022 to a low of $8.0 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 10.00 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Sep 30, 2022 | 16.98 Mn |
| Sep 30, 2022 | 16.98 Mn |
| Mar 31, 2022 | 8.00 Mn |
| Mar 31, 2022 | 8.00 Mn |